# EDGAR Filing Document

**Accession Number:** 0001235912
**File Stem:** 0001104659-26-067606
**Filing Date:** 2026-5
**Character Count:** 5356
**Document Hash:** d7b3a920b2790820b1b5709df23f86b5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-067606.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0001104659-26-067606

**CONFORMED SUBMISSION TYPE**: SD

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260528

**DATE AS OF CHANGE**: 20260528

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CVRx, Inc.
- **CENTRAL INDEX KEY:** 0001235912
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SD
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40545
- **FILM NUMBER:** 261037717

**BUSINESS ADDRESS:**
- **STREET 1:** 9201 WEST BROADWAY AVENUE
- **STREET 2:** SUITE 650
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55445
- **BUSINESS PHONE:** 7634162850

**MAIL ADDRESS:**
- **STREET 1:** 9201 WEST BROADWAY AVENUE
- **STREET 2:** SUITE 650
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55445

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CVRX INC
- **DATE OF NAME CHANGE:** 20030527

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM SD**

Specialized Disclosure Report

**<u>CVRx, Inc.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** <br> (State or other jurisdiction<br> of incorporation) | **001-40545** <br> (Commission <br> File Number) | **41-1983744** <br> (I.R.S. Employer <br> Identification No.) |

---

---

| | |
|:---|:---|
| **9201 West Broadway Avenue, Suite 650**<br> **<u>Minneapolis, MN</u>**<br> (Address of principal executive offices) | <br> **<u>55445</u>**<br> (Zip code) |

---

**Jared Oasheim**

**Chief Financial Officer**

**<u>(763) 416-2840</u>**

(Name and telephone number, including area code, of the person to contact in connection with this report.)

Check the appropriate box to indicate the rule pursuant to which this form is being filed:

⌧ Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2025. <br> ◻ Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended ___.

**Section 1 – Conflict Minerals Disclosure**

**Items 1.01 and 1.02 Conflict Minerals Disclosure and Report, Exhibit**

**Conflict Minerals Disclosure**

As required by Rule 13p-1 (the "Rule"), CVRx, Inc. (the "Company") identified that certain components of the Company's Barostim device that entered the stream of commerce in the calendar year ended December 31, 2025 were potentially in the scope of the Rule for the year ended December 31, 2025.

These components were provided to the Company by a number of contract manufacturers and distributors. The Company conducted a reasonable country of origin inquiry ("RCOI") for the year ended December 31, 2025 but was unable to obtain documentation from some of the relevant suppliers on whether these components contain tin, tungsten, tantalum or gold (the "3TG Minerals"), or if relevant, about the country of origin of any 3TG Minerals incorporated into the products. As a result, the Company cannot rule out the possibility that these products contained 3TG Minerals originating in the Democratic Republic of the Congo or an adjoining country (collectively, the "Covered Countries").

Generally speaking, the amount of information available globally on the traceability and sourcing of these ores is limited at this time. The Company asked its suppliers to provide answers to the Supply Chain Questionnaire adapted from the Conflict Minerals Reporting Template ("CMRT") developed by the Responsible Minerals Initiative reflecting the Company's position on the supply chain. The Company reviewed the questionnaires received for completeness and consistency of answers and asked for corrections and clarifications where needed. As such, the Company believes the RCOI process that it followed was performed in good faith and reasonably designed to determine whether any of the 3TG metals originated in any Covered Country or are from recycled or scrap sources. However, there are inherent limitations in the information provided by third parties including, but not limited to, potential inaccuracies, incompleteness or falsified information despite the Company's efforts to validate and confirm the information.

The information in this Form SD is publicly available on the Company's website at <u>https://ir.cvrx.com/financial-information/sec-filings</u>; however, the information on the Company's website is not incorporated by reference into this Form SD and does not constitute a part of this Form SD.

Pursuant to the Public Statement issued by the SEC's Division of Corporate Finance on April 7, 2017, the Company has provided only the disclosure required under the provisions of paragraphs (a) and (b) of Item 1.01 of Form SD.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

---

| | |
|:---|:---|
| **CVRX, INC.** | **CVRX, INC.** |
| (Registrant) | (Registrant) |
| By: | /s/ Jared Oasheim |
| Name: | Jared Oasheim |
| Title: | Chief Financial Officer |
| Date: | May 28, 2026 |

---